Six-Month Response to Delamanid Treatment in MDR TB Patients

Autor:	Cathy Hewison, Gabriella Ferlazzo, Zaza Avaliani, Armen Hayrapetyan, Sylvie Jonckheere, Zarema Khaidarkhanova, Erika Mohr, Animesh Sinha, Alena Skrahina, Debrah Vambe, Irina Vasilyeva, Nathalie Lachenal, Francis Varaine
Jazyk:	angličtina
Rok vydání:	2017
Předmět:	Tuberculosis multidrug resistance delamanid drug therapy combination antitubercular agents Medicine Infectious and parasitic diseases RC109-216
Zdroj:	Emerging Infectious Diseases, Vol 23, Iss 10, Pp 1746-1748 (2017)
Druh dokumentu:	article
ISSN:	1080-6040 1080-6059
DOI:	10.3201/eid2310.170468
Popis:	Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early treatment results for 53 patients from 7 countries who received a delamanid-containing treatment for MDR TB. Results show good tolerability and treatment response at 6 months.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/8fea9d157f5348aba9806729b1f2f174 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF